LINDSAY A. ROSENWALD, M.D.

Profile

First Name

: LINDSAY

Middle Name

: A.

Last Name

: ROSENWALD, M.D.

Related Companies

Titles

Company Name

Related People

DIRECTOR

OPUS POINT HEALTHCARE INNOVATIONS (OFFSHORE) FUND LTD.

DAWN CUMMINGS, WADE KENNY, KEVIN PHILIPS, MICHAEL S. WEISS

DIRECTOR

AVENUE THERAPEUTICS, INC.

FAITH CHARLES, NEIL HERSKOWITZ, DAVID J. HORIN, DAVID JIN, JAY KRANZLER, M.D., PH.D., LUCY LU, M.D., ALEXANDRA MACLEAN, M.D., CURTIS OLTMANS, JEFFREY PALEY, M.D., SCOTT A. RAINES, M.D., SCOTT A. REINES, M.D., PH.D., MICHAEL RYAN, M.S., AKHTAR SAMAD, M.D. PH.D., MICHAEL WEISS

DIRECTOR

URICA THERAPEUTICS, INC.

JAY D KRANZLER, M.D., PH.D., VIBEKE S. STRAND, M.D., MICHAEL S. WEISS, RAYMOND S. ZHENG

DIRECTOR

MUSTANG BIO, INC.

ADAM J. CHILL, NEIL HERSKOWITZ, MANUEL B. LITCHMAN, M.D., MANUEL S. LITCHMAN, M.D., ELIOT LURIER, JAMES B MURPHY, LINDSAY A. ROSENWALD, MICHAEL S. WEISS, MICHAEL J. ZELEFSKY, M.D.

Filings

Filing Date

Filing Type

Source URL

Industry Classifier

Detailed Industry

Revenue Range

Securities

First Sale Date

D

BIOTECHNOLOGY

PHARMACEUTICAL PREPARATIONS [2834]

DECLINE TO DISCLOSE

2024-06-19

D

BIOTECHNOLOGY

PHARMACEUTICAL PREPARATIONS [2834]

DECLINE TO DISCLOSE

Equity

2023-10-26

D

PHARMACEUTICALS

PHARMACEUTICAL PREPARATIONS [2834]

DECLINE TO DISCLOSE

2023-01-27

D

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Equity

2022-12-27

D/A

HEDGE FUND

2012-09-01

D/A

HEDGE FUND

2012-09-01

D/A

HEDGE FUND

2012-09-01

D/A

HEDGE FUND

2012-09-01

D

BIOTECHNOLOGY

PHARMACEUTICAL PREPARATIONS [2834]

DECLINE TO DISCLOSE

Debt

2016-12-30

D/A

HEDGE FUND

2012-09-01

D/A

HEDGE FUND

2012-09-01